Search clinical trials for: ALKS 4230

Total 333 results

Alkermes, Inc.

Completed

A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

Schizophrenia

United States, Puerto Rico
Alkermes, Inc.

Completed

A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States, Canada
Alkermes, Inc.

Completed

A Phase 1 Safety Study in Adults With Schizophrenia

Schizophrenia

United States
Karolinska Institutet

Completed

The Safety and Efficacy of Intralymphatic Immunotherapy in Pollen Allergic Adolescents and Young Adults With Asthma

Asthma | Allergy | Rhinitis
Conde, Bebiana, M.D.

Completed

Amyotrophic Lateral Sclerosis: a New Paradigm (ALSParadigm)

Amyotrophic Lateral Sclerosis

Portugal
Pharmacosmos A/S
ICON plc

Recruiting

A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia

Beta Thalassemia Major Anemia

Denmark
Revolution Medicines, Inc.
Sanofi; Amgen

Active, not recruiting

Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies

Non-Small Cell Lung Cancer

United States, Korea, Republic of, Canada, Taiwan, Spain, United Kingdom, Italy, Australia, France, Germany
Northwestern University

Completed

Genetics of Familial and Sporadic ALS (ALS)

Amyotrophic Lateral Sclerosis (ALS) | Lou Gehrig's Disease | Primary Lateral Sclerosis (PLS) | Familial Amyotrophic Lateral Sclerosis | ALS With Frontotemporal Dementia (ALS/FTD) | Motor Neuron Disease (MND) | Sporadic ALS (SALS)

United States
Gruppo Italiano Malattie EMatologiche dell'Adulto

Recruiting

Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Autoimmune Hemolytic Anemia | Monoclonal B-Cell Lymphocytosis CLL-Type

Italy
Glycadia
University of Florida

Completed

Phase 1 Study of Anti-glycation Agent GLY-230 in Healthy Subjects

Diabetes

United States
Cytokinetics

Withdrawn

Omecamtiv Mecarbil Post-trial Access Study

Chronic Heart Failure With Reduced Ejection Fraction
The S.N. Fyodorov Eye Microsurgery State Institution

Completed

Femtosecond Laser-assisted Anterior Lamellar Keratoplasty

Corneal Opacity | Keratoconus
Karolinska Institutet
Karolinska University Hospital; Skane University Hospital; Sodra Alvsborgs Hospital

Completed

Intralymphatic Immunotherapy in Increasing Doses, After Subcutaneous Immunotherapy

Rhinitis, Allergic

Sweden
Alkermes, Inc.

Completed

A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)

Major Depressive Disorder

United States, Puerto Rico, Australia
Alkermes, Inc.

Completed

A Study of ALKS 3831 in Adults With Schizophrenia

Schizophrenia

United States, Bulgaria, Czechia
Alkermes, Inc.

Enrolling by invitation

Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

Schizophrenia | Bipolar I Disorder

United States, Argentina, Brazil, Colombia, Mexico
Alkermes, Inc.

Completed

Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I Disorder

Bipolar I Disorder

United States
Forbes Norris MDA/ALS Research Center
Muscular Dystrophy Association

Completed

Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org

Amyotrophic Lateral Sclerosis

United States
Dr. August Wolff GmbH & Co. KG Arzneimittel
SIT Skin Investigation and Technology Hamburg GmbH

Completed

In-Use Test With a Cosmetic Product

Dermatitis, Atopic

Germany
Glycadia

Completed

Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects

Diabetic Nephropathy
Boehringer Ingelheim

Completed

Phase I Dose Escalation of i.v. BI 836909 Monotherapy in Last Line Multiple Myeloma Patients

Multiple Myeloma

Germany, France
Cytokinetics

Withdrawn

Pharmacokinetic Study of Omecamtiv Mecarbil in Heart Failure Patients

Heart Failure
Cancer Institute and Hospital, Chinese Academy...

Recruiting

The Study of Exosome EML4-ALK Fusion in NSCLC Clinical Diagnosis and Dynamic Monitoring

Untreated Advanced NSCLC Patients | FISH Identified ALK Fusion Positive or Negative

China
Advanced Life Sciences, Inc.

Unknown

Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma

Melanoma

United States
Cytokinetics

Completed

Pharmacokinetics and Safety Study of Omecamtiv Mecarbil in Healthy Japanese Adults

Healthy Volunteer

Japan
University of Maryland, College Park
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Hands and Hearts Together

Parent-Child Relations | Parenting | Development, Infant | Development, Child

United States
Universidad Rey Juan Carlos

Completed

Avatar-based Therapy for Female Orgasmic Disorder

Female Orgasmic Disorder

Spain
Bispebjerg Hospital
ALK-Abelló A/S

Completed

Immunological Comparison of AIT and SCIT Immunotherapy Against Grass Pollen

Allergic Rhinitis Due to Grass Pollens

Denmark
Duke University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Transplant Social Worker Support for Live Kidney Donation in African Americans (TALKS)

Kidney Disease

United States
Peking University Third Hospital

Completed

Correlation Between Intestinal Microflora Metabolites and Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

China
Alios Biopharma Inc.

Completed

A Study of ALS-008176 in Infants Hospitalized With RSV

Respiratory Syncytial Virus Infections

United States, Taiwan, Australia, Canada, United Kingdom, Colombia, France, New Zealand, Japan, South Africa, Chile, Panama, Romania, Thailand
Alios Biopharma Inc.
Vertex Pharmaceuticals Incorporated

Terminated

First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Hepatitis C, Chronic

Australia, New Zealand
Alios Biopharma Inc.

Completed

A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus

Respiratory Syncytial Virus Infections

Australia, Singapore, United States, New Zealand, Taiwan
ALK-Abelló A/S

Completed

Safety of ALK Ragweed Tablet

Allergy

United States
Radboud University Medical Center
Exponential Biotherapies Inc.

Unknown

Immunomodulation of EA-230 Following On-pump Coronary Artery Bypass Grafting (CABG) (EASI)

Systemic Inflammatory Response Syndrome | Coronary Artery Bypass Grafting

Netherlands
Glostrup University Hospital, Copenhagen
University of Bergen; National Research Centre for the Working Environment,... and other collaborators

Completed

Effect of Reassuring Information on Danish Workers Who Experience Low Back Pain in the Following Year. (VRRPF)

Non-specific Low Back Pain

Denmark
The University of Hong Kong

Completed

Qigong Intervention Program for Abused Chinese Women

Abused Women

China
Florida State University
National Institute on Minority Health and Health Disparities (NIMHD)

Completed

Addressing Vaccine Hesitancy and Increasing COVID-19 Vaccine Uptake Among African American Young Adults in the South

COVID-19 | Vaccine Uptake

United States
Alios Biopharma Inc.

Completed

Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers

Respiratory Syncytial Virus Infections

France
Hanmi Pharmaceutical Company Limited

Terminated

Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome

Abdominal Obesity Metabolic Syndrome

Korea, Republic of
ALK-Abelló A/S

Completed

Tolerability of Grazax-R in Children

Allergy

Germany
ALK-Abelló A/S

Completed

Tolerability of ALK Grass Tablet in Children

Allergy

Spain
Alios Biopharma Inc.
Vertex Pharmaceuticals Incorporated

Completed

First in Human Study of ALS-002200; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Hepatitis C, Chronic

Moldova, Republic of, Romania, France
ALK-Abelló A/S

Completed

A Trial of the ALK Grass Tablet in Subjects With Hayfever

Allergy

Denmark
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects

Asthma

Denmark
ALK-Abelló A/S

Completed

Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets

Allergy

Spain
Lars Olaf Cardell

Completed

Is Intralymphatic Allergen Immunotherapy Effective and Safe?

Allergic Rhinitis Due to Grass Pollen

Sweden
Biogen
Alkermes, Inc.

Completed

A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2

Relapsing Remitting Multiple Sclerosis

United States, Germany, Poland
Hong Kong Metropolitan University
Chinese University of Hong Kong

Completed

Effects of An ACP Programme for Older People With Early Dementia

Dementia, Mild

Hong Kong
Merck Sharp & Dohme LLC

Completed

Single-Dose Study of MK-4250 Monotherapy in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-4250-002)

HIV-1 Infection

Germany

Search clinical trials for: ALKS 4230

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations